Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Kroes

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pediatric Pulmonology|April 6, 2026
Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis LandscapeSuzanne Kroes, Jennifer L Taylor-Cousar, Marco Zampoli, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2026
A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variantsSuzanne Kroes, Lara Zaidi, Heleen N Sonneveld-van Kooten, et al.
Communications Biology|March 14, 2024
OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretionJuliet W Lefferts, Suzanne Kroes, Matthew B Smith, et al.
International Journal of Molecular Sciences|October 14, 2023
CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare <i>CFTR</i> GenotypesJuliet W Lefferts, Marlou C Bierlaagh, Suzanne Kroes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2024
Elexacaftor/tezacaftor/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controlsSuzanne Kroes, Marlou C Bierlaagh, Juliet W Lefferts, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pediatric Pulmonology|April 6, 2026
Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis LandscapeSuzanne Kroes, Jennifer L Taylor-Cousar, Marco Zampoli, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2026
A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variantsSuzanne Kroes, Lara Zaidi, Heleen N Sonneveld-van Kooten, et al.
Communications Biology|March 14, 2024
OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretionJuliet W Lefferts, Suzanne Kroes, Matthew B Smith, et al.
International Journal of Molecular Sciences|October 14, 2023
CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare <i>CFTR</i> GenotypesJuliet W Lefferts, Marlou C Bierlaagh, Suzanne Kroes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2024
Elexacaftor/tezacaftor/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controlsSuzanne Kroes, Marlou C Bierlaagh, Juliet W Lefferts, et al.
Pageof 1